Regina García

Obesity short‐circuits stemness gene network in human adipose multipotent stem cells

Mar Roldán, Manuel Macías‐González, Regina García et al. · The FASEB Journal · 2011 · 113 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Design and rationale of the QUAZAR Lower-Risk MDS (AZA-MDS-003) trial: a randomized phase 3 study of CC-486 (oral azacitidine) plus best supportive care vs placebo plus best supportive care in patients with IPSS lower-risk myelodysplastic syndromes and poor prognosis due to red blood cell transfusion–dependent anemia and thrombocytopenia

Guillermo Garcia‐Manero, António Almeida, Aristoteles Giagounidis et al. · BMC Hematology · 2016 · 36 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea

Alberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín et al. · Cancer · 2022 · 32 citations · Full text

Medicine, Hematology, Pharmacotherapy +12

Response to erythropoietic‐stimulating agents in patients with chronic myelomonocytic leukemia

Blanca Xicoy, Ulrich Germing, María José Jimenez et al. · European Journal Of Haematology · 2015 · 28 citations

Medicine, Hematology, Oncology +11

Different Clinical Results with the Use of Different Dosing Schedules of Azacitidine in Patients with Myelodysplastic Syndrome Managed in Community-Based Practice: Effectiveness and Safety Data From the Spanish Azacitidine Compassionate Use Registry.

Regina García, Dunia de Miguel, Alicia Bailén et al. · Blood · 2009 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +14